上海復工復產，固生堂(02273.HK)蓄勢待發 乘勝追擊
復工復產，上海門店已陸續恢復營業
近日，上海市制定了《上海市加快經濟恢復和重振行動方案》，並宣佈6月1日起正式復工復產。這對於上海本地的企業是一個重大好消息，方案中提出許多切實的惠民利企業的政策，全面有序推進復工復產復市。
固生堂在上海區域的7家門店將在6月1日後正式恢復正常營業。上海區域醫護團隊已做好周全的計劃，和各位專家溝通出診時間，安排患者有秩序地進行復診。在疫情常態化形勢下，上海門店將貫徹落實以下幾點，爲全面復工復產做好準備：一嚴格執行防控政策，細化落實院感工作。二嚴格做好出入口管理。三定期開展全員培訓，強化監管。四嚴格做好清潔消毒。五嚴格做好外來物品管理。六嚴格做好醫護人員防護。
保駕護航，持續服務患者、醫生、合作夥伴
自上海疫情封控以來，上海區域持續與各區各政府溝通協調，在嚴格按照疫情防控措施的情況下，爲患者提供急需配藥服務，且員工實現0感染。各門診部號召主管和員工入住門診，平均每店入住3人，代煎中心入住20餘人，持續爲患者提供配藥服務、代煎服務等，累計抄方配藥1.16萬人次，累計調劑代煎16.85萬劑。與此同時，公司成立物質保障小分隊，由12輛轎車和2輛物流車組成的物資配送隊伍，爲患者、專家、龍華醫院、嶽陽醫院等合作夥伴配送藥物或物資，專車接送專家出診，累計配送人次約3.26萬人次。
彰顯優勢，互聯網醫療快速發展
互聯網醫療因疫情加速發展，普及度快速提高，結果喜人。公司搭建的互聯網診療平臺讓醫療服務在疫情期間突破地域界限和實體邊界，通過線上問診、視頻問診的方式爲有需要的患者持續提供複診服務，滿足患者用藥的迫切需求。固生堂通過各區各街道告知當地居民線上看診渠道，與老患者持續溝通複診需求，用藥需求訂單源源不斷。醫護人員還密切關注服藥後的情況，及時反饋，及時調整，好評不斷。
公益先行，助力疫情保衛戰
“患難見真情”，固生堂一直關注疫情進展，主動承擔起社會責任，從核酸檢測、物資捐贈等方面主動伸出援手，向社會傳遞正能量。在各地抽調人手組建了30人援護醫療隊，聯合當地醫務團隊，向上海多地派出醫護人員協助核酸檢驗工作，累計完成核酸檢測採樣高達24萬人次。同時，還向上海中醫藥大學，龍華醫院，曙光醫院，市中醫院等捐贈物資，包括：防疫湯藥100包，醫用外科口罩25000個，N95口罩2000個，防護服500套等。
疫情當下，固生堂一直在行動。我們堅信，風雨後一定有彩虹，上海能打贏這場沒有硝煙的戰爭，固生堂也將在復工復產後快速恢復元氣，增長預期指日可待。
來源：固生堂投資者關係
原標題：上海復工復產，固生堂(02273.HK)蓄勢待發 乘勝追擊
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
